EUROPEAN HEART JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2023-05-13 清酌来自上海

偏重的研究方向：临床研究讨论
经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了

661 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2021-12-27 MS54455111222

选刊时有什么原则吗？

4669 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2021-12-27 MS68862005

两个IF相当的期刊，如何选择要投哪个？

3815 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2024-05-08 ms2000000536781631 来自甘肃省

偏重的研究方向：心血管
经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2023-11-20 ms6000001434959802 来自湖北省

我想问一下这个杂志是不是一般都会送审？

535 0

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2023-07-01 1851f102e3m 来自上海

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：心脏
经验分享：2023年IF已超越Circulation 是心血管领域Top 1了

638 0

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2022-03-22 ms5000000159743145

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：冠脉粥样硬化;降脂;超声
经验分享：暂无

4049 0

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2019-06-21 lovetcm

与circulation并驾齐驱，超过JACC不少了

2837 0

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2019-05-25 聪酱

请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表:
明年可能会过20分！与JACC，circulation并架齐驱，是三架马车

lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车

3737 0

[GetPortalCommentsPageByObjectIdResponse(id=2133033, encodeId=758a213303307, content=偏重的研究方向：临床研究讨论 经验分享：2023-05-11投Viewpoint，第二天从Managing editor - submitted to the journal变成Under review。来许愿打卡了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t1eJxKQBgVEfgjAJS68YBkcTZ4RPtz3bYyKTepyYfqBHNpKJLdQGYQjeyjPf8Hedd0CBWXH9VJnEkWSV8lPFrA/132, createdBy=faa62393004, createdName=清酌, createdTime=Sat May 13 00:15:22 CST 2023, time=2023-05-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090206, encodeId=477510902061e, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4669, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090205, encodeId=bee7109020555, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3815, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203467, encodeId=cafb220346e38, content=偏重的研究方向：心血管 经验分享：五月二号（投出去三号），今天8号，under review不知道是内审还是外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 08 16:17:27 CST 2024, time=2024-05-08, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2169834, encodeId=516b216983449, content=我想问一下这个杂志是不是一般都会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29495417578, createdName=ms6000001434959802, createdTime=Mon Nov 20 21:02:29 CST 2023, time=2023-11-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145876, encodeId=b7e221458e6b8, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：心脏 经验分享：2023年IF已超越Circulation 是心血管领域Top 1了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2a62075382, createdName=1851f102e3m, createdTime=Sat Jul 01 23:01:52 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205046, encodeId=e8d41205046e6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：冠脉粥样硬化;降脂;超声 经验分享：暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4049, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fda6566179, createdName=ms5000000159743145, createdTime=Tue Mar 22 21:57:55 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572628, encodeId=b0085e26284d, content=与circulation并驾齐驱，超过JACC不少了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571459, encodeId=761e5e1459d7, content=请问版面费多少？谢谢lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, beContent=lovetcm 2017-10-15 12:38:00 发表: 明年可能会过20分！与JACC，circulation并架齐驱，是三架马车, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3737, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e22090163, createdName=聪酱, createdTime=Sat May 25 00:00:00 CST 2019, time=2019-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569591, encodeId=586d569591b2, content=文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/854f72dc99274c7d8aeee20cc430247c/f50dca65de4a4bd5a52388a0bd1bffc4.jpg, createdBy=67d22225006, createdName=1210f463m66(暂无昵称), createdTime=Tue Apr 16 12:53:00 CST 2019, time=2019-04-16, status=1, ipAttribution=)]

2019-04-16 1210f463m66(暂无昵称)

文章从提交6w后, 拒稿。两个reviewer给的意见很中肯，修改后改投他刊。数据量大的临床型研究建议试投。

2772 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务